GT Biopharma (GTBP) Cash & Current Investments (2010 - 2026)
GT Biopharma (GTBP) recorded Cash & Current Investments of $8.92 million in Q1 2026, up 277.3% from $2.37 million a year earlier and up 31.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma reported Cash & Current Investments of $6.81 million, up 72.4% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 5.2% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $3.95 million in FY2024 (-71.8%), $14 million in FY2023 (-15.2%), $16.51 million in FY2022 (-48.4%) and $31.98 million in FY2021 (+503.7%).
- The Q1 2026 figure is the highest quarterly Cash & Current Investments since Q1 2024.
- On a year-over-year basis, Cash & Current Investments rose in two of the last six quarters, with growth averaging 13.6%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 540.0% in Q3 2023, against a decline of 86.3% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.81 million (Q4 2025), $2.53 million (Q3 2025) and $5.23 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | GT Biopharma | 7.68 Mn | -15.81 Mn | - | 8.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 8.92 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 14.00 Mn |
| Sep 30, 2023 | 16.00 Mn |
| Jun 30, 2023 | 18.00 Mn |
| Mar 31, 2023 | 19.95 Mn |
| Dec 31, 2022 | 16.51 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 5.40 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 31.98 Mn |
| Sep 30, 2021 | 3.90 Mn |
| Jun 30, 2021 | 39.50 Mn |
| Mar 31, 2021 | 27.56 Mn |
API Access
GT Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();